Enveric Biosciences Statistics
NASDAQ: ENVBHealthcareBiotechnologyUSD
1.52+0.025 (+1.67%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Enveric Biosciences by the numbers
Enveric Biosciences has a market capitalization of $6.8 million based on 4.48M shares outstanding. With trailing EPS of $-13.01, Enveric Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.5% above its 50-day average and 31.9% below its 200-day average.
Average daily trading volume is 102.84K shares, or about $156,324 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ENVB valuation vs. peer median
| Metric | ENVB | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.80M | $6.77M | +1% |
| Avg. volume | 102.84K | 106.87K | -4% |
Peer median across 8 companies: LEXX, NRSN, XCUR, CELZ, ALZN, ACXP, APRE, BOLT.
Valuation
- Market cap
- $6.80M
- EPS (TTM)
- $-13.01
- Shares outstanding
- 4.48M
Price and trading
- Previous close
- 1.50
- Open
- 1.47
- Day range
- 1.46 – 1.53
- 52-week range
- 1.17 – 13.25
- Beta
- —
- Volume
- 64.87K
- Average volume
- 102.84K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 6.80M
- Forward Pe
- -1.08
- Eps
- -13.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.25
- Week52 Low
- 1.17
- Avg Volume
- 102.84K
- Shares Outstanding
- 4.48M
- Ma50
- 1.48
- Ma200
- 2.23
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -88.53%
- Pct From52w Low
- 29.91%